Medpace Holdings, Inc. MEDP Lessee Operating Lease Liability Payments Due

Lessee Operating Lease Liability Payments Due at other companies

Veeva SystemsVEEV

——

BridgeBio PharmaBBIO

——

Guardant HealthGH

——

West Pharmaceutical ServicesWST

——

Royalty PharmaRPRX

——

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

See full

Revenue$706.6M+26.5%

Operating income$141.5M+24.6%

Net income$123.9M+8.1%

EPS (diluted)$4.28+16.6%

Balance sheet

See full

Cash & equivalents$652.7M+47.9%

Total debt$146.1M-2.8%

Total equity$598.3M+0.8%

Total assets$2.1B+12.2%

Cash flow

See full

Operating cash flow$151.8M+20.6%

CapEx$6.8M-31.8%

Free cash flow$145.0M+25.1%

Valuation

See full

Market cap$13.14B+46.8%

Enterprise value$12.64B+45.9%

P/E28.6×+7.0×

P/S4.9×+0.8×

Profitability

See full

Operating margin21%-0.1pp

Net margin17.2%-2.1pp

FCF margin26.5%+1.5pp

Returns & leverage

See full

Return on equity77.3%+11.4pp

Debt / equity0.2×0.0×

Current ratio0.8×+0.1×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s lessee operating lease liability payments due.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medpace Holdings, Inc.'s lessee operating lease liability payments due?: Medpace Holdings, Inc. (MEDP) reported lessee operating lease liability payments due of $193.15M in Q1 2026.
How has Medpace Holdings, Inc.'s lessee operating lease liability payments due changed year-over-year?: Medpace Holdings, Inc.'s lessee operating lease liability payments due decreased by 3.3% year-over-year, from $199.81M to $193.15M.